Fernbank Partners with Charco Neurotech to Enhance Awareness of Innovative Parkinson's Therapy

Fernbank Digital Partners with Charco Neurotech to Enhance Awareness of Innovative Parkinson's Therapy

Fernbank Digital, a leading performance marketing agency specialising in lead generation & sales in the health and medical sector, is proud to announce its collaboration with Charco Neurotech, a pioneering medical technology company dedicated to improving the lives of individuals with Parkinson's disease. This partnership aims to amplify the reach and impact of Charco Neurotech's groundbreaking wearable device, the CUE1+, through targeted digital marketing strategies.

Charco Neurotech's CUE1+ is a non-invasive, wearable medical device designed to alleviate motor symptoms associated with Parkinson's disease, such as slowness, stiffness, and freezing of gait. Utilizing pulsed cueing and high-frequency focused vibrotactile stimulation, the device enhances movement and overall quality of life for users. Developed by a dedicated team of designers, engineers, and clinicians, the CUE1+ has already positively impacted over 3,000 individuals, with pilot tests showing an average improvement of 7.8 points in MDS-UPDRS scores—a clinically significant outcome. 

Fernbank Digital will leverage its expertise in Google and YouTube advertising, along with AI-driven lead generation, to create targeted campaigns that inform those affected by Parkinson's about the benefits of the CUE1+ device. The agency will also design optimised landing pages to facilitate seamless lead generation and management whilst simultaneously running direct sales campaigns through Google & Youtube, ensuring that individuals seeking innovative solutions can easily access information and support.

"We're thrilled to be working with the pioneering team at Charco Neurotech, innovators transforming the lives of people living with Parkinson's through groundbreaking wearable neurotechnology—the CUE1+ Device," said Si Lewis, Managing Director of Fernbank Digital. "Together, we're committed to enhancing Charco Neurotech's impact, connecting them with the people who need their products the most." ?

This collaboration underscores Fernbank Digital's commitment to partnering with innovative professional service companies that make a meaningful difference in people's lives. By combining Charco Neurotech's cutting-edge technology with Fernbank's digital marketing prowess, the partnership aspires to bring back smiles for people with Parkinson’s, improving their quality of life through increased awareness and accessibility to the CUE1+ device.

About Fernbank Digital

Founded in 2020 and based in Doncaster, UK, Fernbank Digital specialises in performance marketing focussed on both sales and lead generation. The agency utilises predominantly Google and YouTube ads, AI integration, and custom landing page designs to automate appointment and call bookings across various sectors, including healthcare, property development, and home services. 

About Charco Neurotech

Established in 2019, Charco Neurotech is a medical technology company with the mission to bring back smiles for people with Parkinson's. Their flagship product, the CUE1+, is a non-invasive, wearable device that utilizes focused vibrotactile stimulation and cueing to improve movement and quality of life for individuals with Parkinson's disease. Developed by a team of designers, engineers, and clinicians, Charco Neurotech continues to innovate in the field of neurotechnology to provide effective solutions for long-term conditions.